Schedule 13G ownership disclosure

CONSTELLATION PHARMACEUTICALS INC

Security class unavailable · CUSIP: 210373106

Event date: 2021-03-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
2.8800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-21-000600
Form type
SC 13G
Filer
Cormorant Asset Management, LP
CIK
CIK 1583977
Filed
Apr 09, 2021
Reporting period
Mar 30, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub